• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage publications (all current information on this profile has been aggregated automatically from publisher and metadata sources).
  • Susan J Dutton, David R. Ferry, +18 authors Russell D. Petty
  • Medicine
  • The Lancet. Oncology
  • 2014 (First Published: 1 July 2014)
  • BACKGROUND Evidence is scarce for the effectiveness of therapies for oesophageal cancer progressing after chemotherapy, and no randomised trials have been reported. We aimed to compare gefitinib withContinue Reading
  • Russell D. Petty, Åsa Dahle-Smith, +17 authors David Ferry
  • Medicine
  • 2014 (First Published: 20 May 2014)
  • 4016 Background: The Cancer Oesophagus Gefitinib (COG) trial randomised (1:1) 450 patients(pts) with advanced EC who had progressed after 1-2 lines of chemotherapy to gefitinib (G) or placebo (P).Continue Reading
  • Susan Dutton, Jane M. Blazeby, +18 authors Grp Cogc.
  • Medicine
  • 2013 (First Published: 1 February 2013)
  • 6 Background: There are no randomised trials of 2nd line chemotherapy for esophageal cancer. The phase III COG trial of gefitinib versus placebo in patients with esophageal cancer progressing afterContinue Reading